Sopharma Trading AD Balance Sheet Health
Financial Health criteria checks 5/6
Sopharma Trading AD has a total shareholder equity of BGN124.0M and total debt of BGN181.7M, which brings its debt-to-equity ratio to 146.5%. Its total assets and total liabilities are BGN640.3M and BGN516.3M respectively. Sopharma Trading AD's EBIT is BGN44.7M making its interest coverage ratio 5.6. It has cash and short-term investments of BGN13.1M.
Key information
146.5%
Debt to equity ratio
лв181.68m
Debt
| Interest coverage ratio | 5.6x |
| Cash | лв13.12m |
| Equity | лв124.03m |
| Total liabilities | лв516.32m |
| Total assets | лв640.35m |
Recent financial health updates
No updates
Recent updates
We're Not Counting On Sopharma Trading AD (BUL:SO5) To Sustain Its Statutory Profitability
Feb 14
If You Had Bought Sopharma Trading AD's (BUL:SO5) Shares Three Years Ago You Would Be Down 27%
Dec 18We Wouldn't Rely On Sopharma Trading AD's (BUL:SO5) Statutory Earnings As A Guide
Aug 10
Sopharma Trading AD's (BUL:SO5) Shareholders Are Down 35% On Their Shares
Jul 20Financial Position Analysis
Short Term Liabilities: SFT's short term assets (BGN483.7M) exceed its short term liabilities (BGN431.7M).
Long Term Liabilities: SFT's short term assets (BGN483.7M) exceed its long term liabilities (BGN84.6M).
Debt to Equity History and Analysis
Debt Level: SFT's net debt to equity ratio (135.9%) is considered high.
Reducing Debt: SFT's debt to equity ratio has reduced from 271.2% to 146.5% over the past 5 years.
Debt Coverage: SFT's debt is well covered by operating cash flow (26.4%).
Interest Coverage: SFT's interest payments on its debt are well covered by EBIT (5.6x coverage).